Targeted radionuclide therapy / editor, Tod W. Speer
Contributor(s): Speer, Tod W., editor literario
Material type:
E-bookPublisher: Philadelphia : Lippincott Williams & Wilkins, 2011Description: 1 recurso en línea (XVII, 537 páginas) : ilustraciones.ISBN: 9780781796934; 0781796938.Subject: Cáncer -- Radioterapia
Summary: "Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher.
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC271 .R26 2011 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook121657 |
Incluye referencias bibliográficas e índice
"Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher.
There are no comments on this title.